Authors/Disclosures
Joseph Y. Matsumoto, MD
(University of Minnesota)
|
Dr. Matsumoto has nothing to disclose. |
Bryan T. Klassen, MD
(Mayo Clinic)
|
The institution of Dr. Klassen has received research support from Insightec. |
Ryan J. Uitti, MD, FAAN
(Mayo Clinic of Jacksonville)
|
Dr. Uitti has nothing to disclose. |
|
No disclosure on file |
Laurie A. Schluter, RN, MSN, FNP
(NP Health Solutions)
|
No disclosure on file |
Virgilio Gerald H. Evidente, MD, FAAN
(Movement Disorders Center of Arizona)
|
Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Evidente has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Evidente has received research support from CND. The institution of Dr. Evidente has received research support from Aeon. The institution of Dr. Evidente has received research support from Bukwang Pharmaceuticals. The institution of Dr. Evidente has received research support from Jazz Pharmaceuticals. The institution of Dr. Evidente has received research support from Scion Neurostim. The institution of Dr. Evidente has received research support from Theravance Biopharma. Dr. Evidente has received research support from Cerevance. Dr. Evidente has received research support from Ipsen. |
|
No disclosure on file |
|
No disclosure on file |